Pharmaceutical Regulation Industry and Regulation: PDA and India's Pharmaceutical Industry

Author / Editor: PRASANTA KUMAR CHATTERJEE / Dominik Stephan

Parenteral Drug Association (PDA) is the recognised authoritative voice and leading technical organisation in the field of parenteral science and technology. Through the development of technical reports and responses to regulatory initiatives, PDA and its members influence the future course of pharmaceutical technology. With more than 9,500 individual members worldwide, the organisation draws its strength from the technical expertise of its membership. It is now concentrating on making its presence felt in India. In a tête-à-tête with PROCESS India, Richard M. Johnson, President, PDA, talks about the organisation’s offerings and future plans with regard to India.

Related Companies

"We have two major growth initiatives – one in North America and the other in Asia – specifically in India and China," informs Johnson.
"We have two major growth initiatives – one in North America and the other in Asia – specifically in India and China," informs Johnson.
(Picture: PDA)

PROCESS: PDA was functional in India earlier, however, in between the association lost its visibility. What is its present plan for India?

SRICHARD M. JOHNSON: Parenteral Drug Association (PDA) is a global non-profit organisation. Members here have different backgrounds such as manufacturers, suppliers, regulators in pharmaceutical and biopharmaceutical field and so on. PDA has chapters dedicated to different parts of the world through which our members get opportunity to interact with one another.

These exchanges of technical knowledge and expertise assist the advancement of pharmaceutical science and technology in the interest of public health. Earlier, we had a chapter in India, however, it’s true that due to some reasons there has been a gap.


But, now PDA is again trying to re-establish a chapter here. The key to that effort has been to reach out to people who are currently involved with the Indian pharmaceutical and bio-pharmaceutical industry, to determine what their needs are and their level of interest.

PDA is a volunteer-based organisation. In last two years, we have updated our strategic plan. So, in order to be effective as a group, we need members who are committed to be active in the organisation. Thus, we are trying to reach people in India who are not only interested to join PDA but also are committed to be active. Sartorius India then invited me for a series of presentations and provided me an opportunity to meet with people in the industry face-to-face – and understand their needs – so that PDA can contribute to the growth of the Indian pharma-bio industry.